Regdanvimab
Regdanvimab
Common
Rarity: Common
The most frequent rarity: most Wikipedia articles become Commons.
Rarity follows how well known the article is: its views on the French and English Wikipedia over a year, and the number of languages it exists in.
At a glance
- Class
- Invention
- Domain
- Science and technology
- Knowledge cost
- 1
- In collections
- Nobody has pulled it yet.
What Wikipedia says
Regdanvimab, sold under the brand name Regkirona, is a human monoclonal antibody used for the treatment of COVID-19. The antibody is directed against the spike protein of SARS-CoV-2. It is developed by Celltrion. The medicine is given by infusion (drip) into a vein.
Excerpt from the Wikipedia article “Regdanvimab”, under the CC BY-SA 4.0 license. Read the article on Wikipedia
Open free boosters and add Regdanvimab to your collection.
Play for free




